期刊文献+

结核分枝杆菌38 kD重组蛋白的纯化及血清学诊断应用价值的研究 被引量:2

Purification of recombinant 38 kD protein and application in serodiagnosis of tuberculosis
下载PDF
导出
摘要 目的纯化获得结核分枝杆菌重组38kD蛋白,并评价其在血清学诊断方面的应用价值。方法应用亲和层析方法纯化结核分枝杆菌重组38kD蛋白,应用ELISA方法检测220例血清中的抗结核抗体。结果结核分枝杆菌重组38kD蛋白以包涵体形式表达,以48名正常人血清OD492+2S为正常限值,57例PPD强阳性血清,47例菌阳结核病人血清和68例菌阴结核病人血清阳性检出率分别为13.8%、97.87%和83.82%。结论结核分枝杆菌38kD重组蛋白以包涵体形式高效表达,具有较强的抗原特异性和免疫反应性。 [Objective] To obtain the recombinant 38 kD protein, and evaluate its value in serodiagnosis of tuberculosis. [Methods] The recombinant 38 kD protein was purified by metal chelation chromatography, and its immunogenicity was analyzed in 220 sera by ELISA. [Result] The recombinant 38 kD protein existed in inclusion bodies of TB bacilli. The positive cutoff value was determined as OD492 +2S of 48 sera from PPD-negative healthy people detected by ELISA. Of 57 sera from PPD-positive people, 47 sera from smear-positive tuberculosis patients and 68 sera from smear-negative tuberculosis patients, the positive rates of anti-tuberculosis antibodies were 13.8%, 97.87% and 83.82%, respectively. [Conclusion] The recombinant 38 kD protein could be highly expressed in the form of inclusion bodies in TB bacilli. It had good antigenic specificity and immunoreactivity.
机构地区 解放军第
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2008年第4期426-427,431,共3页 China Journal of Modern Medicine
基金 国家自然科学基金资助项目(30471648)
关键词 结核分枝杆菌 抗原 38 kD重组蛋白 血清学诊断 mycobacterium tuberculosis antigen recombinant 38 kD protein serodiagnosis
  • 相关文献

参考文献1

二级参考文献12

  • 1中华人民共和国卫生部.中国生物制品规程(一部)[M].北京:中国人口出版社,1995.277.
  • 2何秀云 庄玉辉 等.结核分枝杆菌38000蛋白抗原诱发豚鼠迟发性超敏反应的研究[J].防痨信息,1999,2(1):3-3.
  • 3Kabival JV,Chapras SD,Hussong D.Characterization of seriological and cell-mediated reactivity of a 38Kda antigen isolated from mycobacterium tuberculosis.J Immun,1987;139:2447~2451
  • 4Haslqv K,Anderson A,Nagal S,et al.Guinea pig cellular immune responses to protein secreted by mycobacterium tuberculosis.Infect Immune,1995;63:804~810
  • 5Dtting T,Holm A,Haslqv K.Characteriation of the delayed type hypersenstitivity-inducing epitope of the MPT64 from mycobacterium tuberculosis.Scand.J Immunol,1997;45:449~503
  • 6Martin JE,Thomas O,Peter A,Delayed-type hypersensitivity response to ESAT6 and MPT4 from M.Tuberculosis in the guinea pig.Infection and Immunity,1998;66:3454~3456
  • 7Worsaae A,Ljungqvist K,Haslqv I,et al.Allergenic and blastogeinc reactivity of three antigens from M.tuberculosis in sensitized guinea pigs. Infect Immun,1987;55:2922~2927
  • 8Andersen AB,Ha nsen EB.Structure and mapping of antigen domains of protein antigen b,a 38000-molecular-weight protein of Mycobacterium tuberculosis.Infect Immun,1989;57:2481~2488
  • 9Wikinson RJ,Haslav K,Rappuoli R,et al.Evaluation of the recombinant 38-kilodalton antigen of Mycobacterium tuberculosis as a potential immunodiagnostic reagent.J Clin Microbiol,1997;35:553~557
  • 10Henry P,Godfrey,Zuohua F,et al.Modulation of expression of delayed hypersensitivity by mycobacterial antigen 85 fibronectin-binding protein.Infect Immun,1992;60:2522~2528

共引文献1

同被引文献17

  • 1Wu X,Yang Y,Zhang J,et al.Comparison of antibody responses to seventeen antigens from Mycobacterium tuberculosis.Clin Chim Acta,2010,411:1520-1528.
  • 2Kumar G,Dagur PK,Singh PK,et al.Serodiagnostic efficacy of myco-bacterium tuberculosis30/32-kDa mycolyl transferase complex,ESAT-6,and CFP-10in patients with active tuberculosis.Arch Immunol Ther Exp(Warsz),2010,58:57-65.
  • 3Wu X,Yang Y,Zhang J,et al.Humoral immune responses against the mycobacterium tuberculosis38-Kilodalton,MTB48,and CFP-10/ES-AT-6antigens in tuberculosis.Clin Vaccine Immunol,2010,17:372-375.
  • 4Renshaw PS,Lightbody KL,Veverka V,et al.Structure and function of the complex formed by the tuberculosis virulence factors CFP-10and ESAT-6.EMBO J,2005,24:2491-2498.
  • 5中国防痨协会基础专业委员会.结核病诊断实验室检验规程[M].北京:中国教育出版社,2006.13-16.
  • 6SAMBROOK J, FRITSCH E F, MANIATIS T. 分子克隆实验指南.2版.金冬雁,黎孟枫,译.北京:科学出版社出版,1992.
  • 7World Health Organization. Global tuberculosis control key finding from the December 2009 WHO report[ R]. 2010, 85:69 -80.
  • 8World Health Organization. Global Tuberculosis Control, surveil- lance, planning, financing, 2003 [ R ]. 2003,67:71 - 73.
  • 9中华医学会结核病学分会.肺结核诊断和治疗指南[J].中国防痨杂志,2011,24(2):70-74.
  • 10World Health Organization. WHO Tuberculosis Diagnostics Workss- hop product development guidelines[ R]. 1997, 1 -27.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部